十一月 2025
- Home
- Rutgers Cancer Institute of New Jersey
十一月 2025的Rutgers Cancer Institute...市场份额分析
rutgers cancer institute in partnership with rwjbarnabas health brings together the top cancer researchers and clinicians throughout new jersey to apply the latest technologies, therapies, & approaches to improve cancer diagnosis, treatment,
Rutgers Cancer Institute of New Jersey(包含公司地区分支机构)
查看更多网站流量和参与度信息- cinj.org
Rutgers Cancer Institute of New Jersey收入截至 十一月 2025为 100M - 200M
Rutgers Cancer Institute of New Jersey主要域名产生的收入
3 年中Rutgers Cancer Institute of New Jersey主要域名的收入
Rutgers Cancer Institute of New Jersey主要域名的收入
Rutgers Cancer Institute of New Jersey热门域名的总访问量
了解Rutgers Cancer Institute of New Jersey市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Rutgers Cancer Institute of New Jersey热门域名的平均访问时长
分析Rutgers Cancer Institute of New Jersey参与度指标。
过去 3 个月的平均访问时长
子公司明细
Rutgers Cancer Institute of New Jersey热门域名的平均页面浏览量
了解Rutgers Cancer Institute of New Jersey如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Rutgers Cancer Institute of New Jersey 排名靠前的竞争对手(按域名)
十一月 2025的热门相似网站,按亲和力排名
标杆分析您的数字绩效
识别高价值机会,跟踪您的表现,赢得市场。
Rutgers Cancer Institute of New Jersey 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Haystack Oncology, Inc. partnered with The Cancer Institute of New Jersey on Sep 22nd '25.Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, today announced a research collaboration with the Rutgers Cancer Institute to evaluate the use of Haystack MRD(R), a highly sensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) test, to help optimize
九月 22, 2025阅读更多
新闻The Cancer Institute of New Jersey hires Contessa.Contessa joins Rutgers from Yale University, where he served as professor of therapeutic radiology, co-leader of the Yale Cancer Center Radiobiology and Genome Integrity Research Program, and vice chair for basic science research in therapeutic radiology, among other leadership roles.
八月 6, 2025阅读更多
新闻The Cancer Institute of New Jersey is developing risk prediction model for early-stage classic hodgkin's lymphoma.RWJBarnabas Health, Rutgers Cancer Institute, tufts medical center, and the university of manchester develop first risk prediction model for early-stage classic hodgkin's lymphoma.
六月 19, 2025阅读更多
查看 Rutgers Cancer Institute of New Jersey 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。